A Study of TeriQ Patch in Healthy Adult Female Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This will be a single center, open-label, active-controlled, 3-way, incomplete block, crossover, randomized, and single escalating dose study.
Epistemonikos ID: 816f29bfaa7089fd0b78190175efbbd3b9f12572
First added on: Nov 01, 2024